Oral Cephalexin Dosing for eGFR 10 mL/min/1.73 m²
For a patient with eGFR 10 mL/min/1.73 m², reduce cephalexin to 250 mg every 8-12 hours or 500 mg every 12-24 hours, with the specific interval determined by infection severity and clinical response.
Dosing Algorithm for Severe Renal Impairment
The FDA label 1 establishes standard dosing of 250 mg every 6 hours to 500 mg every 12 hours for adults, but explicitly states this applies to normal renal function. With an eGFR of 10 mL/min/1.73 m², you are dealing with near-anephric kidney function requiring substantial dose reduction.
Evidence-Based Dose Adjustment
The pharmacokinetic data demonstrates that:
- In patients with creatinine clearance of 0 mL/min (anephric), cephalexin half-life increases from approximately 1 hour (normal) to 8.5-15.4 hours 2, 3
- The elimination rate constant (Ke) correlates directly with creatinine clearance: Ke = 0.0766 + 0.0060 × CrCl 2
- At eGFR 10, approximately 90% of normal renal clearance is lost 4
Practical Dosing Recommendations
For mild-to-moderate infections:
- Start with 250 mg every 12 hours
- This provides adequate serum levels while preventing accumulation
For severe infections:
- Use 500 mg every 12-24 hours
- The longer half-life (approximately 7-8 hours at this eGFR) maintains therapeutic levels even with extended intervals
Loading dose consideration:
- A standard 500 mg loading dose is reasonable to achieve rapid therapeutic levels 3
- Follow with reduced maintenance dosing as above
Critical Caveats
Dialysis Considerations
If the patient is on hemodialysis (common at eGFR 10), cephalexin is dialyzable 2. Administer a supplemental dose of 250-500 mg after each dialysis session to replace drug removed during treatment.
Monitoring Requirements
- Watch for drug accumulation signs: altered mental status, seizures (rare but reported with cephalosporin accumulation)
- The guideline evidence 5 for chronic suppressive therapy suggests 500 mg three to four times daily for normal renal function, but this must be proportionally reduced for eGFR 10
Alternative Consideration
The prosthetic joint infection guideline 5 lists cephalexin 500 mg TID-QID for chronic suppression, but this dosing assumes normal renal function and requires adjustment as outlined above. The footnote explicitly states "antimicrobial dosage needs to be adjusted based on patients' renal and hepatic function" 5.
Why This Matters for Outcomes
Inadequate dose reduction risks:
- Neurotoxicity from drug accumulation (seizures, encephalopathy)
- Hematologic toxicity (neutropenia has been documented even at standard doses 6)
Excessive dose reduction risks:
- Treatment failure with inadequate bacterial killing
- Resistance development from subtherapeutic levels
The research demonstrates that patients with creatinine clearance <30 mL/min require proportional dose reduction 4, and at eGFR 10, you're operating at approximately 10% of normal renal function, necessitating the conservative approach outlined above.